Results 181 to 190 of about 167,720 (353)

Anakinra Pilot - a clinical trial to demonstrate safety, feasibility and pharmacokinetics of interleukin 1 receptor antagonist in preterm infants. [PDF]

Front Immunol, 2022
Green EA, Metz D, Galinsky R, Atkinson R, Skuza EM, Clark M, Gunn AJ, Kirkpatrick CM, Hunt RW, Berger PJ, Nold-Petry CA, Nold MF, Nold MF.   +12 more
europepmc   +1 more source

418 DEVELOPMENT OF A THERMALLY RESPONSIVE DRUG DEPOT FOR INTRA-ARTICULAR DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST TO ATTENUATE INFLAMMATORY EVENTS IN OSTEOARTHRITIS

, 2007
Mohammed F. Shamji, Helawe Betre, J. Chen, V.B. Kraus, Ashutosh Chilkoti, Lori A. Setton   +5 more
openalex   +1 more source

Involvement of Tumor Necrosis Factor-α in the Development of T Cell–Dependent Aortitis in Interleukin-1 Receptor Antagonist–Deficient Mice [PDF]

, 2005
Taizo Matsuki, Kikuo Isoda, Reiko Horai, Akiko Nakajima, Yoshifusa Aizawa, Kazuo Suzuki, Fumitaka Ohsuzu, Yoichiro Iwakura   +7 more
openalex   +1 more source

Microenvironment Self‐Adaptive Nanoarmor to Address Adhesion‐ and Colonization‐Related Obstacles in Impaired Intestine Promote Bacteriotherapy Against Parkinson's Disease

Advanced Science, EarlyView.
A microenvironment self‐adaptive nanoarmor is developed to effectively address the adhesion‐ and colonization‐related challenges posed by multiple physiological and pathological characteristics in the intestine. L. plantarum@MPN@CS showed significant therapeutic potential in treating Parkinson's disease (PD), a model for extraintestinal disorders, as ...
Limeng Zhu, Yuyu Wu, Yingjie Chen, Xiyi Chen, Xingjie Zan, Yanlong Liu, Wujun Geng   +6 more
wiley   +1 more source

Association of Interleukin-1 Receptor Antagonist ( IL-1RA ) Gene Polymorphism with Community-Acquired Pneumonia in North Indian Children: A Case-Control Study. [PDF]

Glob Med Genet, 2023
Verma N, Awasthi S, Pandey AK, Gupta P.
europepmc   +1 more source

Post-infection immunocomplex glomerulonephritis and Legionnaires' disease in a patient with adult Still's disease during treatment with interleukin 1 receptor antagonist anakinra: a case report [PDF]

, 2011
Dieter Scholtze, Zsuzsanna Varga, Alexander Imhof   +2 more
openalex   +1 more source

Type I Interferon Pathway Activation Disrupts Monocyte Maturation and Enhances Immune Evasion in Multiple Myeloma

Advanced Science, EarlyView.
This study shows that monocytes in multiple myeloma display an excessive interferon response, leading to transcriptional reprogramming and altered differentiation. Using single‐cell sequencing, coculture experiments, and patient samples before and after therapy, the authors demonstrate that induction treatment reduces this interferon response ...
Jian Cui, Jingwei Wang, Xiaoyun Li, Lina Wang, Xuehan Mao, Rui Lyv, Wenqiang Yan, Jingyu Xu, Jieqiong Zhou, Chenxing Du, Shuhui Deng, Mu Hao, Yan Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Xin Gao, Lugui Qiu, Gang An   +18 more
wiley   +1 more source

Letter to the editor - "Re: Tinea labialis in a patient with Schnitzler syndrome on interleukin-1 receptor antagonist". [PDF]

JAAD Case Rep
Velusamy B, Pincelli T, Sokumbi O.
europepmc   +1 more source

Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH). [PDF]

Eur Stroke J, 2023
Parry-Jones AR, Stocking K, MacLeod MJ, Clarke B, Werring DJ, Muir KW, Vail A.   +6 more
europepmc   +1 more source

The pharmacological study of hypoglycemic properties of the recombinant antagonist interleukin-1 receptor

, 2015
I. P. Bukhtiyarova, К. Г. Щокіна, С. М. Дроговоз, O. M. Ischenko   +3 more
openalex   +2 more sources